Live feed
Filing
SC 13G/A
SC 13G/A0000315066-18-002426·X4 Pharmaceuticals, Inc
Schedule 13G ownership disclosure
Arsanis, Inc.
Security class unavailable · CUSIP: 042873109
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 0.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-18-002426
- Form type
- SC 13G/A
- Filer
- X4 Pharmaceuticals, Inc
- CIK
- CIK 1501697
- Filed
- Oct 10, 2018
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership